Skip to main content
. 2020 Jul 16;12:5881–5891. doi: 10.2147/CMAR.S258875

Table 2.

Cytogenetics of MDS Patients with or without Myelofibrosis

Cytogenetics Myelofibrosis (Number of Cases) p
Grade 0
(n = 123, %)
Grade 1–2
(n = 34, %)
Abnormal 68 (55.3%) 16 (47.1%) 0.40
Monosomal karyotype 11 (8.9%) 3 (8.8%) 1.00
Complex karyotype 8 (6.5%) 3 (8.8%) 0.71
5q- 18 (14.6%) 1 (2.9%) 0.077
-5 6 (4.9%) 0 (0%) 0.34
7q- 9 (7.3%) 3 (8.8%) 0.72
-7 14 (11.4%) 4 (11.8%) 1.00
+8 22 (17.9%) 9 (22.6%) 0.27
20q- 20 (16.3%) 2 (5.9%) 0.17
-Y 5 (4.1%) 0 (0%) 0.59